Welcome

Minhu Chen   

*Head-to-head trial of biological therapies in inflammatory bowel disease

Stefan Schreiber   

*Long-term outcomes of perianal fistulizing Crohn's disease by different biologics

Silvio Danese   

*Safety of ustekinumab or vedolizumab in inflammatory bowel disease

Janneke van der Woude   

Closing Remarks

Laurent Peyrin-Biroulet